GlassScriptPhysician profile
Lynn Swisher
NPI 1659392538
$4,070.34
in general payments reported to CMS, 2019-2025
17 companies · $241 in 2025
The $241 reported for 2025 was more than what a typical provider received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $459 · 2020: $167 · 2021: $1,792 · 2022: $490 · 2023: $489 · 2024: $433 · 2025: $241.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,162.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,162.12 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $1,818.74 | 2021-2025 | Azure Xt Dr Mri Surescan, Micra |
| Biotronik INC. | $1,021.90 | 2019-2025 | Amvia Edge, Biomonitor, Edora 8 Dr-T |
| Medtronic Vascular, INC. | $261.64 | 2019 | |
| Impulse Dynamics (USA) INC. | $163.70 | 2023-2024 | Optimizer, Optimizer |
| Novo Nordisk INC | $128.36 | 2022 | |
| Abbott Laboratories | $121.32 | 2024-2025 | Jot Dx, Amplatzer Amulet |
| Boehringer Ingelheim Pharmaceuticals, INC. | $107.17 | 2019-2021 | |
| Astellas Pharma US INC | $99.95 | 2022 | |
| Novartis Pharmaceuticals Corporation | $91.56 | 2022-2025 | |
| Bracco Diagnostics INC. | $62.61 | 2024-2025 | |
| Lantheus Medical Imaging, INC. | $58.61 | 2019-2022 | |
| Amgen INC. | $32.72 | 2024 | Repatha |
| Pfizer INC. | $28.81 | 2022-2023 | |
| Kiniksa Pharmaceuticals International, Plc | $24.24 | 2024 | Arcalyst |
| Bard Peripheral Vascular, INC. | $18.04 | 2024 | Crosser Iq |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lexicon Pharmaceuticals, INC. | $16.56 | 2024 | |
| Janssen Pharmaceuticals, INC | $14.41 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lynn Swisher listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.